Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Glen Rock, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
RespireRx Pharmaceuticals Inc. has filed 926 SEC EDGAR filings since 30 Oct 1995

SEC filing history

Showing 451-475 of 517 matching filings.

Per page
25
Current page
19
4

PRIMARY DOCUMENT

Filing date
24 Oct 2011
Reporting date
20 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8-K

Filing date
06 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-16467

CT ORDER filing

Filing date
21 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-171788

AMENDMENT NO. 1 TO FORM S-1

Filing date
07 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8-K

Filing date
18 Aug 2011
Reporting date
18 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
144/A File 001-16467

FORM 144/A

Filing date
17 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-16467

FORM 12B-25

Filing date
15 Aug 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8-K

Filing date
08 Aug 2011
Reporting date
02 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-16467

CT ORDER filing

Filing date
28 Jun 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8-K

Filing date
14 Jun 2011
Reporting date
10 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 May 2011
Reporting date
25 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 May 2011
Reporting date
20 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8-K

Filing date
23 May 2011
Reporting date
23 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-16467

FORM 10-Q

Filing date
23 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 May 2011
Reporting date
18 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2011
Reporting date
16 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-16467

FORM 144

Filing date
18 May 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-16467

NOTIFICATION OF LATE FILING

Filing date
17 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

FORM 8-K

Filing date
21 Mar 2011
Reporting date
15 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-16467

CORTEX PHARMACEUTICALS, INC. FORM 10-K

Filing date
18 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-16467

CORTEX PHARMACEUTICALS FORM 8-K

Filing date
18 Mar 2011
Reporting date
18 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2011
Reporting date
01 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2011
Reporting date
01 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2011
Reporting date
01 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .